Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NAIP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | PRR5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | NANOS3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | ARHGAP32 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | REXO2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | TMEM198 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | LRRC74B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | GLS2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | GPR63 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | BAZ2B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |